BC3 Technologies (BC3T, focus is on developing novel and effective antihemorrhagic products for the medical, military, and general consumer sectors. BC3T’s proprietary chitosan-based aerosol product allows ease of application on wounds as well high-clotting ability which rivals against competitors’ products in both performance and cost. The biggest differentiator for BC3T’s technology compared to others is that the chitosan-based product has maximized hemostatic activity, great stability, and wide-range of applications.